STOCK TITAN

MannKind (MNKD) director adds 12,000 shares via Market Price Stock Purchase Plan

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

MannKind Corp director Shannon James Samuel acquired 12,000 shares of common stock at a price of $3.27 per share. The acquisition was made through the company’s Market Price Stock Purchase Plan, which was approved by the Board of Directors on March 1, 2026.

Following this grant or award acquisition, Samuel’s direct holdings increased to 64,635 shares of MannKind common stock. This transaction reflects participation in a board-approved stock purchase plan rather than an open-market trading decision.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Shannon James Samuel

(Last) (First) (Middle)
1 CASPER STREET

(Street)
DANBURY CT 06810

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
MANNKIND CORP [ MNKD ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
03/01/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, $0.01 Par Value 03/01/2026 A(1) 12,000 A $3.27 64,635 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The securities were purchased through the Issuer's Market Price Stock Purchase Plan. The purchase was approved by the Company's Board of Directors on March 1, 2026.
/s/ James S Shannon 03/03/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did MannKind Corp (MNKD) report for Shannon James Samuel?

MannKind reported that director Shannon James Samuel acquired 12,000 shares of common stock at $3.27 per share. The shares were obtained through the company’s Market Price Stock Purchase Plan approved by the Board on March 1, 2026.

How many MannKind (MNKD) shares does Shannon James Samuel own after this Form 4 transaction?

After this transaction, Shannon James Samuel directly owns 64,635 MannKind common shares. This total reflects the addition of 12,000 shares acquired via the Market Price Stock Purchase Plan approved by the Board of Directors on March 1, 2026.

What was the price per share in Shannon James Samuel’s MannKind (MNKD) stock acquisition?

The reported acquisition price was $3.27 per share for 12,000 MannKind common shares. These shares were obtained through the Issuer’s Market Price Stock Purchase Plan, rather than a discretionary open-market purchase by the director.

Was Shannon James Samuel’s MannKind (MNKD) transaction part of a stock plan?

Yes. The Form 4 notes the securities were purchased through MannKind’s Market Price Stock Purchase Plan. The company’s Board of Directors approved this stock purchase plan transaction on March 1, 2026, indicating it was a structured, board-sanctioned acquisition.

What type of insider transaction is reported for MannKind (MNKD) on this Form 4?

The Form 4 shows a grant, award, or other acquisition coded as “A” for 12,000 non-derivative common shares. It is categorized as an acquisition rather than an open-market buy, executed through the Market Price Stock Purchase Plan.
Mannkind

NASDAQ:MNKD

MNKD Rankings

MNKD Latest News

MNKD Latest SEC Filings

MNKD Stock Data

898.18M
296.70M
Biotechnology
Pharmaceutical Preparations
Link
United States
DANBURY